Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (4886)	11/6/2001 12:28:50 PM
From: blackmerlin	Read Replies (1) \| Respond to of 52153

Peter: Thank you for the clarification & Fidelity information. I think we are not going to see the big short-term leaps in BMY & PFE, for example, as in biotech. But, I still think having a few of these helps and that the large pharma may pick up now. Your view on fund managers is interesting. I would expect that smaller biotech funds with managers with biotech company experience from the technical side or from experience from being on a lot of Biotech Board, or early-stage VC, would do well in picking biotech stocks. Best regards, Jake